Becker's Healthcare January 2, 2025
Elizabeth Gregerson

Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature.

For the study, international researchers reviewed 245 academic articles from 46 countries to analyze the scale of COVID-19’s disruption on cancer care.

Here are four notes from their analysis:

  1. In addition to the 39% decline in cancer screening, diagnostic procedures declined by 24% and cancer diagnoses declined by 23% compared to prepandemic levels.
  2. Cancer treatment declined by 28% overall, with a 15% decline in radiotherapy treatment and a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Related Articles:
How Climate-Driven Disasters Could Reshape Health Care Quality Measures
Journalists Discuss Health Care for Incarcerated Children and the Possibility of a Bird Flu Pandemic
What Is HKU5-CoV-2? Scientists Find Bat Virus Similar To COVID-19
Insights into the future of COVID-19 care
Texas Measles Outbreak Nears 100 Cases, Raising Concerns About Undetected Spread

Share This Article